Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

5:35 PM - 5:45 PM PT

151 - Bladder Only vs. Whole Pelvis Radiotherapy in Trimodality Treatment for Lymph Node Negative Urothelial Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
Speaker: Granda, Alyssa Anne, MD - Jose R. Reyes Memorial Medical Center, Manila, Metro Manila
5:35 PM - 5:45 PM PT

157 - A Multi-Site Single-Arm Phase I/II Trial of Selective Avoidance of Nodal VolumEs at Minimal Risk (SAVER) in the Contralateral N0 Neck of Patients with p16-Positive Oropharynx Cancer
Speaker: Molitoris, Jason, MD, PhD - University of Maryland School of Medicine, Baltimore, MD
5:35 PM - 5:45 PM PT

163 - Real World Validation of a Head and Neck Specific Patient-Reported Outcome CTCAE Measure in a Radiation Oncology Clinic
Speaker: Razavian, Niema, MD - Moffitt Cancer Center, Tampa, FL
5:35 PM - 5:45 PM PT

170 - Pediatric Radiation Oncology with Movie Induced Sedation Effect (PROMISE): A Phase II Clinical Trial to Safely Reduce Anesthesia Use
Speaker: Kumar, Kiran, MD, MBA - UT Southwestern Medical Center, Dallas, TX
5:35 PM - 5:45 PM PT

176 - Does Dose Avoidance of Uninvolved Skin/Subcutaneous Tissues Reduce Morbidity in Preoperative Intensity-Modulated Radiation Therapy for Soft Tissue Sarcomas of the Lower Extremity?
Speaker: Roohani, Siyer, MD - Princess Margaret Cancer Center, University Health Network, Toronto, ON
5:45 PM - 5:55 PM PT

164 - Characterizing Symptom Trajectories in Prostate Cancer Patients Receiving Radiation Therapy
Speaker: Lee, Minji, PhD - Mayo Clinic Rochester, Rochester, MN
5:45 PM - 5:55 PM PT

Discussant
Speaker: Lukens, John, MD - University of Pennsylvania Health System, Philadelphia, PA
5:45 PM - 5:55 PM PT

Discussant
Speaker: Mouw, Kent, MD, PhD - Brigham & Womens' Hospital/Dana-Farber Cancer Institute, Boston, MA
5:45 PM - 5:55 PM PT

Discussant
Speaker: Lyons, Janice, MD, FASTRO - University Hospitals - Seidman Cancer Center, Cleveland, OH

Monday, September 29

8:00 AM - 8:10 AM PT

177 - Development and Validation of a Digital Pathology-Based, Multimodal Artificial Intelligence (MMAI) Biomarker in Patients with Head and Neck Cancer
Speaker: Chinn, Steven, MD - University of Michigan, Ann Arbor, MI
8:00 AM - 8:10 AM PT

183 - 10-Year Neuropsychological and QoL Outcomes in Pediatric Brain Tumor Survivors: A Comparison of Photon and Proton Cohorts
Speaker: Yock, Torunn, MD, FASTRO, MCH - Massachusetts General Hospital, Boston, MA
8:00 AM - 8:10 AM PT

188 - RC48-ADC Combined with Radiotherapy and Immunotherapy as Salvage Therapy for Advanced Solid Tumors with HER2 Expression: A Multicenter, Phase II Trial
Speaker: Xu, Meiling, MD, PhD, RT - The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu